Effects of uroguanylin on natriuresis in experimental nephrotic rats

Nephrology

Volumn 14, Issue 1, 2009, Pages 80-85

  Baba, Akiko ^a,b   Fujimoto, Shouichi ^a   Kikuchi, Masao ^a   Kita, Toshihiro ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Natriuresis; Nephrotic syndrome; PAN induced nephrosis; Sodium retention; Uroguanylin

Indexed keywords

CREATININE; PUROMYCIN AMINONUCLEOSIDE; SODIUM; UROGUANYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLUID BALANCE; IMMUNOREACTIVITY; MALE; NATRIURESIS; NEPHROTIC SYNDROME; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; SODIUM RETENTION; URINARY EXCRETION;

ANIMALS; GUANYLATE CYCLASE; MALE; NATRIURESIS; NATRIURETIC PEPTIDES; NEPHROTIC SYNDROME; RATS; RATS, SPRAGUE-DAWLEY;

EID: 63149192244     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01006.x     Document Type: Article

References (25)

1. Forte LR, London RM, Freeman RH, Krause WJ. Guanylin peptides: Renal actions mediated by cyclic GMP. Am. J. Physiol. Renal Physiol. 2000 278 : F180 91.
2. Forte LR. Uroguanylin and guanylin peptides: Pharmacology and experimental therapeutics. Pharmacol. Ther. 2004 104 : 137 62.
3. Fan X, Wang Y, London RM et al. Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems. Endocrinology 1997 138 : 4636 48.
4. Fonteles MC, Greenberg RN, Monteiro HAS, Currie MG, Forte LR. Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am. J. Physiol. 1998 275 : F191 7.
5. Greenberg RN, Hill M, Crytzer J et al. Comparison of effects of uroguanylin, guanylin, Escherichia coli heart-stable enterotoxin STa in mouse intestine and kidney: Evidence that uroguanylin is an intestinal natriuretic hormone. J. Investig. Med. 1997 45 : 276 82.
6. Carrithers SL, Hill MJ, Johnson BR et al. Renal effects of uroguanylin and guanylin in vivo. Braz. J. Med. Biol. Res. 1999 32 : 1337 44.
7. Carrithers SL, Ott CE, Hill MJ et al. Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor. Kidney Int. 2004 65 : 40 53.
8. Fukae H, Kinoshita H, Fujimoto S, Kita T, Nakazato M, Eto T. Changes in urinary levels and renal expression of uroguanylin on low or high salt diets in rats. Nephron 2002 92 : 373 8.
9. Kita T, Kitamura K, Sakata J, Eto T. Marked increased of guanylin secretion in response to salt loading in the rat small intestine. Am. J. Physiol. 1999 277 : G960 6.
10. Lorenz JN, Nieman M, Sabo J et al. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J. Clin. Invest. 2003 112 : 1244 54.
11. Kinoshita H, Fujimoto S, Kita T et al. Urine and plasma levels of uroguanylin and its molecular forms in renal disease. Kidney Int. 1997 52 : 1028 34.
12. Kinoshita H, Fujimoto S, Fukae H et al. Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 1999 81 : 160 64.
13. Carrithers SL, Eber SL, Forte LR, Greenberg RN. Increased urinary excretion of uroguanylin in patients with congestive heart failure. Am. J. Physiol. Heart Circ. Physiol. 2000 278 : H538 47.
14. Nakazato M, Yamaguchi H, Kinoshita H et al. Identification of biologically active and inactive human uroguanylin in plasma and urine and their increases in renal insufficiency. Biochem. Biophys. Res. Commun. 1996 220 : 586 93.
15. Kikuchi M, Fujimoto S, Fukae H et al. Rule of uroguanylin, a peptide with natriuretic activity, in rats with experimental nephritic syndrome. J. Am. Soc. Nephrol. 2005 16 : 392 7.
16. Perico N, Remuzzi G. Edema of the nephrotic syndrome: The role of the atrial peptide system. Am. J. Kidney Dis. 1993 22 : 355 66.
17. Perico N, Delaini F, Lupini C et al. Blunted excretory response to atrial natriuretic peptide in experimental nephrosis. Kidney Int. 1989 36 : 57 64.
18. Keller E, Hoppe-Seyler G, Shollmeyer P. Disposition and diuretic effect of furosemide in nephrotic syndrome. Clin. Pharmacol. Ther. 1982 32 : 442 9.
19. Sindic A, Basoglu C, Cerci A et al. Guanylin, uroguanylin, and heat-stable euterotoxin activate guanylate cyclase C and/or a pertussis toxin-sensitive G protein in human proximal tubule cells. J. Biol. Chem. 2002 277 : 17758 64.
20. Sindic A, Velic A, Basoglu C et al. Uroguanylin and guanylin regulate transport of mouse cortical collecting duct independent of guanylate cyclase C. Kidney Int. 2005 68 : 1008 17.
21. Sindic A, Hirsch JR, Velic A, Piechota H, Schlatter E. Guanylin and uroguanylin regulate electrocyte transport in isolated human cortical collecting ducts. Kidney Int. 2005 67 : 1420 27.
22. Elitsur N, Lorenz JN, Hawkins JA et al. The proximal convoluted tubule is a target for the uroguanylin-regulated natriuretic response. J. Pediatr. Gastroenterol. Nutr. 2006 43 : S74 81.
23. Sindic A, Schlatter E. Cellular effects of guanylin and uroguanylin. J. Am. Soc. Nephrol. 2006 17 : 607 16.
24. Sindic A, Schlatter E. Mechanisms of action of uroguanylin and guanylin and their role in salt handling. Nephrol. Dial. Transplant. 2006 21 : 3007 12.
25. Valentin JP, Ying WZ, Sechi L et al. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann nephritis. J. Am. Soc. Nephrol. 1996 7 : 582 93.